Bleeding Complications Associated with Low Molecular Weight Heparin Prophylaxis during Pregnancy

Thromb Haemost 2000; 84(01): 140-141
DOI: 10.1055/s-0037-1613984

Letters to the Editor

Schattauer GmbH

Authors

P. G. Lindqvist

¹From the Dept. of Obstetrics and Gynecology, Malmö University Hospital, Univ. Lund, Malmö, Sweden
B. Dahlbäck

¹From the Dept. of Obstetrics and Gynecology, Malmö University Hospital, Univ. Lund, Malmö, Sweden

References
1 Dahlman TC. Osteoporotic fractures and the recurrence of thromboembo-lism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-70.
2 Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Lutherkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
3 Lindqvist P, Dahlbäck B, Marsal K. Thrombotic risk during Pregnancy, a Population Study. Obstet Gynecol 1999; 94: 595-9.
4 Matthiasson SE, Lindblad B, Matzsch T, Molin J, Qvarford P, Bergqvist D. Study of the interaction of dextran and enoxaparin on haemostasis in humans. Thromb Haemost 1994; 72: 722-7.